A blood test developed by Roche and Eli Lilly that could help diagnose patients with Alzheimer's disease more quickly has been cleared for marketing in the US. The FDA has approved the Elecsys pTau181 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback